We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Sublingual Immunotherapy for the Treatment of Allergic Rhinoconjunctivitis and Asthma.
- Authors
Lin, Sandra Y.; Erekosima, Nkiruka; Kim, Julia M.; Ramanathan, Murugappan; Suarez-Cuervo, Catalina; Chelladurai, Yohalakshmi; Ward, Darcy; Segal, Jodi B.
- Abstract
The article focuses on a study related to the use of sublingual immunotherapy for the treatment of allergic rhinoconjunctivitis and asthma in the U.S. It informs that though sublingual immunotherapy is not approved by the U.S. Food and Drug Administration, yet some physicians use aqueous allergens for sublingual desensitization. Several databases and the Cochrane Central Register of Controlled Trials were searched. It also informs that overall evidence provides a moderate grade level of evidence to support the effectiveness of sublingual immunotherapy for the treatment of allergic rhinitis and asthma.
- Subjects
UNITED States; IMMUNOTHERAPY; RHINITIS treatment; ASTHMA treatment; UNITED States. Food &; Drug Administration; DATABASES; PHYSICIANS; ALLERGENS
- Publication
JAMA: Journal of the American Medical Association, 2013, Vol 309, Issue 12, p1278
- ISSN
0098-7484
- Publication type
Article
- DOI
10.1001/jama.2013.2049